• News
  • Finance

What Global Financial Crisis? Capital Markets Back Biotechs

Biopharmaceutical drugmakers have made up for a sluggish start to 2012 - despite turbulence in the global capital markets - to perform well in the 3Q, according to an analysis of financings and stock values by BioWorld.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!